Evidence map›Paper›PMID 29422862›Full record

ArticleFrontiers in pharmacology2018

Geraniol Pharmacokinetics, Bioavailability and Its Multiple Effects on the Liver Antioxidant and Xenobiotic-Metabolizing Enzymes.

Barbara Pavan, Alessandro Dalpiaz, Luca Marani, Sarah Beggiato, Luca Ferraro, Donatella Canistro, Moreno Paolini, Fabio Vivarelli, Maria C Valerii, Antonietta Comparone and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Monoterpenoid synergy: a new frontier in biological applications.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  18. Article
  19. Article
  20. Unveiling novel insights: geraniol's enhanced anti-candida efficacy and mechanistic innovations against multidrug-resistant candida strains.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Barbara PavanDepartment of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Alessandro DalpiazDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Luca MaraniDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Sarah BeggiatoDepartment of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Luca FerraroDepartment of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Donatella CanistroDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Moreno PaoliniDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Fabio VivarelliDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Maria C ValeriiDepartment of Biological, Geological and Environmental Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Antonietta ComparoneDepartment of Biological, Geological and Environmental Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Luigia De FazioDepartment of Biological, Geological and Environmental Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Enzo SpisniDepartment of Biological, Geological and Environmental Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
University of Bologna · ITUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Geraniol is a natural monoterpene showing anti-inflammatory, antioxidant, neuroprotective and anticancer effects. No pharmacokinetic and bioavailability data on geraniol are currently available. We therefore performed a systematic study to identify the permeation properties of geraniol across intestinal cells, and its pharmacokinetics and bioavailability after intravenous and oral administration to rats. In addition, we systematically investigated the potential hepatotoxic effects of high doses of geraniol on hepatic phase I, phase II and antioxidant enzymatic activities and undertook a hematochemical analysis on mice. Permeation studies performed via HPLC evidenced geraniol permeability coefficients across an

Indexed as

bioavailabilitygeraniolgutpharmacokineticsxenobiotic-metabolizing enzymes

Identifiers

PMID29422862
PMCPMC5788896
OpenAlexW2792317437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.